Skip to main content
Top
Published in: BMC Cancer 1/2006

Open Access 01-12-2006 | Research article

Significance of somatic mutations and content alteration of mitochondrial DNA in esophageal cancer

Authors: Duan-Jun Tan, Julia Chang, Ling-Ling Liu, Ren-Kui Bai, Yu-Fen Wang, Kun-Tu Yeh, Lee-Jun C Wong

Published in: BMC Cancer | Issue 1/2006

Login to get access

Abstract

Background

The roles of mitochondria in energy metabolism, the generation of ROS, aging, and the initiation of apoptosis have implicated their importance in tumorigenesis. In this study we aim to establish the mutation spectrum and to understand the role of somatic mtDNA mutations in esophageal cancer.

Methods

The entire mitochondrial genome was screened for somatic mutations in 20 pairs (18 esophageal squamous cell carcinomas, one adenosquamous carcinoma and one adenocarcinoma) of tumor/surrounding normal tissue of esophageal cancers, using temporal temperature gradient gel electrophoresis (TTGE), followed by direct DNA sequencing to identify the mutations.

Results

Fourteen somatic mtDNA mutations were identified in 55% (11/20) of tumors analyzed, including 2 novel missense mutations and a frameshift mutation in ND4L, ATP6 subunit, and ND4 genes respectively. Nine mutations (64%) were in the D-loop region. Numerous germline variations were found, at least 10 of them were novel and five were missense mutations, some of them occurred in evolutionarily conserved domains. Using real-time quantitative PCR analysis, the mtDNA content was found to increase in some tumors and decrease in others. Analysis of molecular and other clinicopathological findings does not reveal significant correlation between somatic mtDNA mutations and mtDNA content, or between mtDNA content and metastatic status.

Conclusion

Our results demonstrate that somatic mtDNA mutations in esophageal cancers are frequent. Some missense and frameshift mutations may play an important role in the tumorigenesis of esophageal carcinoma. More extensive biochemical and molecular studies will be necessary to determine the pathological significance of these somatic mutations.
Appendix
Available only for authorised users
Literature
1.
go back to reference Attardi G, Schatz G: Biogenesis of mitochondria. Annu Rev Cell Biol. 1988, 4: 289-333. 10.1146/annurev.cb.04.110188.001445.CrossRefPubMed Attardi G, Schatz G: Biogenesis of mitochondria. Annu Rev Cell Biol. 1988, 4: 289-333. 10.1146/annurev.cb.04.110188.001445.CrossRefPubMed
2.
go back to reference Wallace DC, Shoffner JM, Trounce I, Brown MD, Ballinger SW, Corral-Debrinski M, et al: Mitochondrial DNA mutations in human degenerative diseases and aging. Biochim Biophys Acta. 1995, 1271: 141-151.CrossRefPubMed Wallace DC, Shoffner JM, Trounce I, Brown MD, Ballinger SW, Corral-Debrinski M, et al: Mitochondrial DNA mutations in human degenerative diseases and aging. Biochim Biophys Acta. 1995, 1271: 141-151.CrossRefPubMed
3.
go back to reference Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, et al: Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science. 2000, 287: 2017-2019. 10.1126/science.287.5460.2017.CrossRefPubMed Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, et al: Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science. 2000, 287: 2017-2019. 10.1126/science.287.5460.2017.CrossRefPubMed
4.
go back to reference Hibi K, Nakayama H, Yamazaki T, Takase T, Taguchi M, Kasai Y, et al: Mitochondrial DNA alteration in esophageal cancer. Int J Cancer. 2001, 92: 319-321. 10.1002/ijc.1204.CrossRefPubMed Hibi K, Nakayama H, Yamazaki T, Takase T, Taguchi M, Kasai Y, et al: Mitochondrial DNA alteration in esophageal cancer. Int J Cancer. 2001, 92: 319-321. 10.1002/ijc.1204.CrossRefPubMed
5.
go back to reference Liu VW, Shi HH, Cheung AN, Chiu PM, Leung TW, Nagley P, et al: High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res. 2001, 61: 5998-6001.PubMed Liu VW, Shi HH, Cheung AN, Chiu PM, Leung TW, Nagley P, et al: High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res. 2001, 61: 5998-6001.PubMed
6.
go back to reference Polyak K, Li Y, Zhu H, Lengauer C, Willson JK, Markowitz SD, et al: Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet. 1998, 20: 291-293. 10.1038/3108.CrossRefPubMed Polyak K, Li Y, Zhu H, Lengauer C, Willson JK, Markowitz SD, et al: Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet. 1998, 20: 291-293. 10.1038/3108.CrossRefPubMed
7.
go back to reference Tan DJ, Bai RK, Wong LJ: Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res. 2002, 62: 972-976.PubMed Tan DJ, Bai RK, Wong LJ: Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res. 2002, 62: 972-976.PubMed
8.
go back to reference Tan DJ, Chang J, Chen WL, Agress LJ, Yeh KT, Wang B, et al: Novel heteroplasmic frameshift and missense somatic mitochondrial DNA mutations in oral cancer of betel quid chewers. Genes Chromosomes Cancer. 2003, 37: 186-194. 10.1002/gcc.10217.CrossRefPubMed Tan DJ, Chang J, Chen WL, Agress LJ, Yeh KT, Wang B, et al: Novel heteroplasmic frameshift and missense somatic mitochondrial DNA mutations in oral cancer of betel quid chewers. Genes Chromosomes Cancer. 2003, 37: 186-194. 10.1002/gcc.10217.CrossRefPubMed
9.
go back to reference Copeland WC, Wachsman JT, Johnson FM, Penta JS: Mitochondrial DNA alterations in cancer. Cancer Invest. 2002, 20: 557-569. 10.1081/CNV-120002155.CrossRefPubMed Copeland WC, Wachsman JT, Johnson FM, Penta JS: Mitochondrial DNA alterations in cancer. Cancer Invest. 2002, 20: 557-569. 10.1081/CNV-120002155.CrossRefPubMed
10.
go back to reference Kirches E, Krause G, Warich-Kirches M, Weis S, Schneider T, Meyer-Puttlitz B, et al: High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples. Int J Cancer. 2001, 93: 534-538. 10.1002/ijc.1375.CrossRefPubMed Kirches E, Krause G, Warich-Kirches M, Weis S, Schneider T, Meyer-Puttlitz B, et al: High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples. Int J Cancer. 2001, 93: 534-538. 10.1002/ijc.1375.CrossRefPubMed
11.
go back to reference Kurtz A, Lueth M, Kluwe L, Zhang T, Foster R, Mautner VF, et al: Somatic mitochondrial DNA mutations in neurofibromatosis type 1-associated tumors. Mol Cancer Res. 2004, 2: 433-441.PubMed Kurtz A, Lueth M, Kluwe L, Zhang T, Foster R, Mautner VF, et al: Somatic mitochondrial DNA mutations in neurofibromatosis type 1-associated tumors. Mol Cancer Res. 2004, 2: 433-441.PubMed
12.
go back to reference Wong LJ, Tan DJ, Bai RK, Yeh KT, Chang J: Molecular alterations in mitochondrial DNA of hepatocellular carcinomas: is there a correlation with clinicopathological profile?. J Med Genet. 2004, 41: e65-10.1136/jmg.2003.013532.CrossRefPubMedPubMedCentral Wong LJ, Tan DJ, Bai RK, Yeh KT, Chang J: Molecular alterations in mitochondrial DNA of hepatocellular carcinomas: is there a correlation with clinicopathological profile?. J Med Genet. 2004, 41: e65-10.1136/jmg.2003.013532.CrossRefPubMedPubMedCentral
13.
go back to reference Wong LJ, Lueth M, Li XN, Lau CC, Vogel H: Detection of mitochondrial DNA mutations in the tumor and cerebrospinal fluid of medulloblastoma patients. Cancer Res. 2003, 63: 3866-3871.PubMed Wong LJ, Lueth M, Li XN, Lau CC, Vogel H: Detection of mitochondrial DNA mutations in the tumor and cerebrospinal fluid of medulloblastoma patients. Cancer Res. 2003, 63: 3866-3871.PubMed
14.
go back to reference Badenhop RF, Cherian S, Lord RS, Baysal BE, Taschner PE, Schofield PR: Novel mutations in the SDHD gene in pedigrees with familial carotid body paraganglioma and sensorineural hearing loss. Genes Chromosomes Cancer. 2001, 31: 255-263. 10.1002/gcc.1142.CrossRefPubMed Badenhop RF, Cherian S, Lord RS, Baysal BE, Taschner PE, Schofield PR: Novel mutations in the SDHD gene in pedigrees with familial carotid body paraganglioma and sensorineural hearing loss. Genes Chromosomes Cancer. 2001, 31: 255-263. 10.1002/gcc.1142.CrossRefPubMed
15.
go back to reference Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, et al: Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science. 2000, 287: 848-851. 10.1126/science.287.5454.848.CrossRefPubMed Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, et al: Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science. 2000, 287: 848-851. 10.1126/science.287.5454.848.CrossRefPubMed
16.
go back to reference Taschner PE, Jansen JC, Baysal BE, Bosch A, Rosenberg EH, Brocker-Vriends AH, et al: Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene. Genes Chromosomes Cancer. 2001, 31: 274-281. 10.1002/gcc.1144.CrossRefPubMed Taschner PE, Jansen JC, Baysal BE, Bosch A, Rosenberg EH, Brocker-Vriends AH, et al: Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene. Genes Chromosomes Cancer. 2001, 31: 274-281. 10.1002/gcc.1144.CrossRefPubMed
17.
go back to reference Tomlinson IP, Alam NA, Rowan AJ, Barclay E, Jaeger EE, Kelsell D, et al: Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet. 2002, 30: 406-410. 10.1038/ng849.CrossRefPubMed Tomlinson IP, Alam NA, Rowan AJ, Barclay E, Jaeger EE, Kelsell D, et al: Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet. 2002, 30: 406-410. 10.1038/ng849.CrossRefPubMed
18.
go back to reference Gimm O, Armanios M, Dziema H, Neumann HP, Eng C: Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma. Cancer Res. 2000, 60: 6822-6825.PubMed Gimm O, Armanios M, Dziema H, Neumann HP, Eng C: Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma. Cancer Res. 2000, 60: 6822-6825.PubMed
19.
go back to reference Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, et al: Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 1997, 275: 1129-1132. 10.1126/science.275.5303.1129.CrossRefPubMed Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, et al: Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 1997, 275: 1129-1132. 10.1126/science.275.5303.1129.CrossRefPubMed
20.
go back to reference Isidoro A, Martinez M, Fernandez PL, Ortega AD, Santamaria G, Chamorro M, et al: Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer. Biochem J. 2004, 378: 17-20. 10.1042/BJ20031541.CrossRefPubMedPubMedCentral Isidoro A, Martinez M, Fernandez PL, Ortega AD, Santamaria G, Chamorro M, et al: Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer. Biochem J. 2004, 378: 17-20. 10.1042/BJ20031541.CrossRefPubMedPubMedCentral
21.
go back to reference Cuezva JM, Chen G, Alonso AM, Isidoro A, Misek DE, Hanash SM, et al: The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis. Carcinogenesis. 2004, 25: 1157-1163. 10.1093/carcin/bgh113.CrossRefPubMed Cuezva JM, Chen G, Alonso AM, Isidoro A, Misek DE, Hanash SM, et al: The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis. Carcinogenesis. 2004, 25: 1157-1163. 10.1093/carcin/bgh113.CrossRefPubMed
22.
go back to reference Parrella P, Xiao Y, Fliss M, Sanchez-Cespedes M, Mazzarelli P, Rinaldi M, et al: Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res. 2001, 61: 7623-7626.PubMed Parrella P, Xiao Y, Fliss M, Sanchez-Cespedes M, Mazzarelli P, Rinaldi M, et al: Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res. 2001, 61: 7623-7626.PubMed
23.
go back to reference Tamura G, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Sakata K, et al: Mutations in mitochondrial control region DNA in gastric tumours of Japanese patients. Eur J Cancer. 1999, 35: 316-319. 10.1016/S0959-8049(98)00360-8.CrossRefPubMed Tamura G, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Sakata K, et al: Mutations in mitochondrial control region DNA in gastric tumours of Japanese patients. Eur J Cancer. 1999, 35: 316-319. 10.1016/S0959-8049(98)00360-8.CrossRefPubMed
24.
go back to reference Richard SM, Bailliet G, Paez GL, Bianchi MS, Peltomaki P, Bianchi NO: Nuclear and mitochondrial genome instability in human breast cancer. Cancer Res. 2000, 60: 4231-4237.PubMed Richard SM, Bailliet G, Paez GL, Bianchi MS, Peltomaki P, Bianchi NO: Nuclear and mitochondrial genome instability in human breast cancer. Cancer Res. 2000, 60: 4231-4237.PubMed
25.
go back to reference Hu N, Dawsey SM, Wu M, Bonney GE, He LJ, Han XY, et al: Familial aggregation of oesophageal cancer in Yangcheng County, Shanxi Province, China. Int J Epidemiol. 1992, 21: 877-882.CrossRefPubMed Hu N, Dawsey SM, Wu M, Bonney GE, He LJ, Han XY, et al: Familial aggregation of oesophageal cancer in Yangcheng County, Shanxi Province, China. Int J Epidemiol. 1992, 21: 877-882.CrossRefPubMed
26.
go back to reference Abnet CC, Huppi K, Carrera A, Armistead D, McKenney K, Hu N, et al: Control region mutations and the 'common deletion' are frequent in the mitochondrial DNA of patients with esophageal squamous cell carcinoma. BMC Cancer. 2004, 4: 30-10.1186/1471-2407-4-30.CrossRefPubMedPubMedCentral Abnet CC, Huppi K, Carrera A, Armistead D, McKenney K, Hu N, et al: Control region mutations and the 'common deletion' are frequent in the mitochondrial DNA of patients with esophageal squamous cell carcinoma. BMC Cancer. 2004, 4: 30-10.1186/1471-2407-4-30.CrossRefPubMedPubMedCentral
27.
go back to reference Mark SD, Qiao YL, Dawsey SM, Wu YP, Katki H, Gunter EW, et al: Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst. 2000, 92: 1753-1763. 10.1093/jnci/92.21.1753.CrossRefPubMed Mark SD, Qiao YL, Dawsey SM, Wu YP, Katki H, Gunter EW, et al: Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst. 2000, 92: 1753-1763. 10.1093/jnci/92.21.1753.CrossRefPubMed
28.
go back to reference Kumimoto H, Yamane Y, Nishimoto Y, Fukami H, Shinoda M, Hatooka S, et al: Frequent somatic mutations of mitochondrial DNA in esophageal squamous cell carcinoma. Int J Cancer. 2004, 108: 228-231. 10.1002/ijc.11564.CrossRefPubMed Kumimoto H, Yamane Y, Nishimoto Y, Fukami H, Shinoda M, Hatooka S, et al: Frequent somatic mutations of mitochondrial DNA in esophageal squamous cell carcinoma. Int J Cancer. 2004, 108: 228-231. 10.1002/ijc.11564.CrossRefPubMed
29.
go back to reference Wong LJ, Liang MH, Kwon H, Park J, Bai RK, Tan DJ: Comprehensive scanning of the entire mitochondrial genome for mutations. Clin Chem. 2002, 48: 1901-1912.PubMed Wong LJ, Liang MH, Kwon H, Park J, Bai RK, Tan DJ: Comprehensive scanning of the entire mitochondrial genome for mutations. Clin Chem. 2002, 48: 1901-1912.PubMed
30.
go back to reference Wong LJ, Chen TJ, Tan DJ: Detection of mitochondrial DNA mutations using temporal temperature gradient gel electrophoresis. Electrophoresis. 2004, 25: 2602-2610. 10.1002/elps.200406016.CrossRefPubMed Wong LJ, Chen TJ, Tan DJ: Detection of mitochondrial DNA mutations using temporal temperature gradient gel electrophoresis. Electrophoresis. 2004, 25: 2602-2610. 10.1002/elps.200406016.CrossRefPubMed
31.
go back to reference Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, et al: Sequence and organization of the human mitochondrial genome. Nature. 1981, 290: 457-465. 10.1038/290457a0.CrossRefPubMed Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, et al: Sequence and organization of the human mitochondrial genome. Nature. 1981, 290: 457-465. 10.1038/290457a0.CrossRefPubMed
32.
go back to reference Bai RK, Perng CL, Hsu CH, Wong LJ: Quantitative PCR analysis of mitochondrial DNA content in patients with mitochondrial disease. Ann N Y Acad Sci. 2004, 1011: 304-309. 10.1196/annals.1293.029.CrossRefPubMed Bai RK, Perng CL, Hsu CH, Wong LJ: Quantitative PCR analysis of mitochondrial DNA content in patients with mitochondrial disease. Ann N Y Acad Sci. 2004, 1011: 304-309. 10.1196/annals.1293.029.CrossRefPubMed
33.
go back to reference Wong LJ, Alper OM: Detection of CFTR mutations using temporal temperature gradient gel electrophoresis. Electrophoresis. 2004, 25: 2593-2601. 10.1002/elps.200406015.CrossRefPubMed Wong LJ, Alper OM: Detection of CFTR mutations using temporal temperature gradient gel electrophoresis. Electrophoresis. 2004, 25: 2593-2601. 10.1002/elps.200406015.CrossRefPubMed
34.
go back to reference Lee HC, Li SH, Lin JC, Wu CC, Yeh DC, Wei YH: Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma. Mutat Res. 2004, 547: 71-78.CrossRefPubMed Lee HC, Li SH, Lin JC, Wu CC, Yeh DC, Wei YH: Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma. Mutat Res. 2004, 547: 71-78.CrossRefPubMed
35.
go back to reference Yin PH, Lee HC, Chau GY, Wu YT, Li SH, Lui WY, et al: Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma. Br J Cancer. 2004, 90: 2390-2396.PubMedPubMedCentral Yin PH, Lee HC, Chau GY, Wu YT, Li SH, Lui WY, et al: Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma. Br J Cancer. 2004, 90: 2390-2396.PubMedPubMedCentral
36.
go back to reference Wong LJ, Perng CL, Hsu CH, Bai RK, Schelley S, Vladutiu GD, et al: Compensatory amplification of mtDNA in a patient with a novel deletion/duplication and high mutant load. J Med Genet. 2003, 40: e125-10.1136/jmg.40.11.e125.CrossRefPubMedPubMedCentral Wong LJ, Perng CL, Hsu CH, Bai RK, Schelley S, Vladutiu GD, et al: Compensatory amplification of mtDNA in a patient with a novel deletion/duplication and high mutant load. J Med Genet. 2003, 40: e125-10.1136/jmg.40.11.e125.CrossRefPubMedPubMedCentral
Metadata
Title
Significance of somatic mutations and content alteration of mitochondrial DNA in esophageal cancer
Authors
Duan-Jun Tan
Julia Chang
Ling-Ling Liu
Ren-Kui Bai
Yu-Fen Wang
Kun-Tu Yeh
Lee-Jun C Wong
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2006
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-6-93

Other articles of this Issue 1/2006

BMC Cancer 1/2006 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine